Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1411 S Garfield Ave Ste 306&308
Alhambra, CA 91801Phone+1 626-312-9500Fax+1 626-312-9588
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2001
- Mercy Catholic Medical CenterResidency, Internal Medicine, 1994 - 1997
- Shanghai Jiao Tong University School of MedicineClass of 1982
Certifications & Licensure
- CA State Medical License 1997 - 2025
- PA State Medical License 1995 - 2000
Publications & Presentations
PubMed
- 6 citationsRuxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma.James R Berenson, Daisy Martinez, Tahmineh Safaie, Ralph Boccia, Honghao Yang
British Journal of Haematology. 2023-03-01 - 73 citationsOvercoming Drug Resistance in Multiple Myeloma: The Emergence of Therapeutic Approaches to Induce ApoptosisHank H. Yang, Mark H. Ma, Robert Vescio, James R. Berenson
Journal of Clinical Oncology. 2003-11-15 - A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia
Targeted Oncology. 2024-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: